Supply of Diphenhydramine HCl Pharmaceutical Product

The contract entails the supply and delivery of three units of FDA-approved Diphenhydramine Hydrochloride, identified by NDC 10135-0166-13 and NSN 6505001320294, in commercial packaging that meets all applicable pharmaceutical standards. The product will be shipped FOB Destination to a U.S. military medical facility, ensuring the medication arrives in a condition suitable for immediate clinical use. This transaction is structured as a subcontract under the Defense Logistics Agency, which operates under the Department of Defense, and is classified under NAICS code 325412 for pharmaceutical and biological product manufacturing. The solicitation was posted on June 24, 2026, and is part of a broader effort to maintain consistent availability of essential pharmaceuticals within military healthcare systems. While no specific set-aside details or point of contact are provided, the contract is linked to the DLA’s procurement portal and will be fulfilled under the contract ID SPE2DX25D9900 with delivery referenced under DLV SPE2DP26F6787. Compliance with regulatory and logistical requirements is critical to ensure the integrity of the drug supply chain and readiness for military medical operations.